The Consumer’s Guide to Biologics for Ankylosing Spondylitis
Understanding how biologics work and their benefits and risks will help you have a productive conversation with your healthcare provider when deciding whether these medications are right for you and how to work them into your treatment plan.
How Biologics Work for Ankylosing Spondylitis
Unlike synthetic medications such as nonsteroidal anti-inflammatory drugs (NSAIDs), biologics are created using living cells similar to molecules in your immune system.
How Biologics Work for Ankylosing Spondylitis

Next up video playing in 10 seconds
Understanding Ankylosing Spondylitis: A Type of Inflammatory Arthritis
How Biologics Target Ankylosing Spondylitis Inflammation
7 Essential Facts About Biologics for Ankylosing Spondylitis
1. There Are Numerous Biologic Medications Approved for Treating Ankylosing Spondylitis
Biologics approved by the U.S. Food and Drug Administration for AS include eight original, or reference, drugs as well as biosimilars, which are medications that closely resemble the originals but are typically less expensive.

TNF-Alpha Inhibitors
- adalimumab (Humira) and biosimilars
- certolizumab pegol (Cimzia)
- etanercept (Enbrel) and biosimilars
- infliximab (Remicade) and biosimilars
- golimumab (Simponi)

IL-17 Inhibitors
- ixekizumab (Taltz)
- secukinumab (Cosentyx)
- bimekizumab-bkzx (Bimzelx)

2. Biologics Are Administered by Infusion or Injection
Biologics for AS aren’t available in pill form. They must be administered either through an intravenous (IV) infusion at a medical office or clinic or as an injection you can give yourself at home.
“Biologics are a special class of medications that are made using live cultures that generate large proteins with the ability to suppress the immune system — called antibodies. Our gut cannot absorb the antibody as a whole and would break it apart. This is why we need to inject it into the lower tummy or the upper thigh to bypass the gastrointestinal tract,” says Ayad Alkhatib, MD, a rheumatologist and senior staff physician at Henry Ford Health in Michigan.
“Most biologics are administered using auto-injectors,” adds Jonathan Kay, MD, the Timothy S. and Elaine L. Peterson Chair in Rheumatology at the UMass Chan Medical School in Worcester, Massachusetts. “They use very small-gauge needles, which hardly hurt and don’t cause significant discomfort.”
How often you’ll need to take a biologic varies. “Drugs such as adalimumab are typically administered every other week, etanercept is administered weekly, golimumab is administered monthly, certolizumab pegol is administered every other week, and ixekizumab and secukinumab are administered monthly,” says Dr. Kay.

3. Most People Will Start to Feel Relief Within a Few Months
Your symptoms may begin to improve within a few weeks after starting a biologic, or it may take a couple months to notice a difference. Your symptoms may continue to improve for months afterward.

4. Biologics May Help Prevent Related Health Conditions
By reducing inflammation in your body, biologics may help reduce your risk of developing health conditions related to AS, such as uveitis (eye inflammation), inflammatory bowel disease, and cardiovascular disease.

5. Biologics May Become Less Effective Over Time
You may notice that a biologic works less well after you’ve taken it for months or years. This may be because your immune system can develop antibodies that bind to the particular medication, reducing its effectiveness. If this happens, your AS symptoms may start to come back. If a biologic no longer works for you, switching to a different one might do the trick.

6. Biologics Are Considered Safe But Do Have Some Risks
As with any medication, biologics come with potential risks and side effects. The most common are pain and swelling at the injection site. Skin reactions are generally mild and go away on their own, but if you experience symptoms such as shortness of breath, dizziness, or fever, call your doctor or seek emergency care, since these could be signs of an allergic reaction to the medication.
Because biologics suppress your immune system, they also increase your risk of bacterial and fungal infections. What’s more, they may activate latent (inactive) infections, including tuberculosis and viral hepatitis (like hepatitis B), so you will need to be tested for these before starting a biologic. If you develop an infection while taking a biologic, it’s important to tell your doctor immediately so you can be treated.

7. Insurance Usually Covers Biologics
The eight original biologics can be expensive, costing tens of thousands of dollars per year or even more. Biosimilars tend to be much cheaper but are still pricey for many people. Most insurance companies will cover at least part of this cost, but how much and what you’ll need to pay out of pocket depends on your insurance plan.
How you take the drug may also affect whether insurance covers it. “Medicare covers hospital-administered intravenous medications,” says Kay. “So someone who’s on Medicare who needs a TNF inhibitor might benefit from, say, infliximab infusions, since they’re covered by insurance in a way that is different from outpatient-administered, self-administered injectables.”
If you’re concerned about paying for your medication, talk to your doctor, who can work with you to determine the best biologic for your insurance coverage and treatment needs. Your healthcare team can also discuss financial assistance — state programs, pharmacy discount programs, and prescription assistance programs through the drug manufacturers — that can help you get your medication for less money or even no cost.

Is It Time to Try a Biologic to Treat Ankylosing Spondylitis?
“If symptoms are limiting and interfering with your daily activities, especially in the morning and [lasting longer] than 30 minutes, or if you find it difficult to sleep comfortably during the night and wake up due to pain, then it would be reasonable to discuss with your rheumatologist the need to be on biologics,” says Dr. Alkhatib.
Your exact treatment plan will depend on a number of factors, including your disease severity, personal preferences, medical history, and overall health.
A Rheumatologist Answers Your Questions About Biologics
Alkhatib answers the most common questions he hears from patients.
Steps for Self-Reflection

Before your next appointment, reflect on these questions, which your doctor might ask about your treatment plan.
- Are you satisfied with your current ankylosing spondylitis treatment?
- Has it improved your pain and other ankylosing spondylitis symptoms as well as you had hoped?
- How often do you have to cancel plans or adjust activities because of ankylosing spondylitis?
- Are you downplaying your symptoms — or their impact on your quality of life — to your doctor?
- Are you following your treatment regimen as prescribed?
- Have you tried other treatment options yet?
Conversation Starters for Talking to Your Doctor

If you decide it’s time to discuss a potential treatment change with your doctor, jot down some questions you’d like to ask. Here are a few conversation starters that you can save to your phone and bring to your next doctor’s appointment.
- What can I do to improve my pain and stiffness?
- Am I a good candidate for biologics?
- Which medication are you prescribing for me and why?
- What results do you expect?
- How long should I use this medication before monitoring the progress?
The Takeaway
- Biologics are a type of disease-modifying antirheumatic drug; they work by targeting some aspects of your immune system, relieving inflammation and associated symptoms of ankylosing spondylitis.
- Biologics can be a good treatment option for AS if other therapies haven’t worked or if your symptoms limit you and interfere with your quality of life.
- It’s important to discuss options with your managing physician or rheumatologist to decide on the best treatment course for your condition.
Additional reporting by Debra Fulghum Bruce, PhD, and Erin Coakley.
Resources We Trust
- Cleveland Clinic: Ankylosing Spondylitis
- Spondylitis Association of America: Treatment of Spondylitis
- Arthritis Foundation: Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis
- Spondylitis Association of America: SAA’s Spondyloarthritis Educational Support Groups
- Spondylitis Association of America: Where to Go for Assistance With Medical and Prescription Costs
- Biologic Therapy. National Axial Spondyloarthritis Society.
- A Guide to Biologic Therapy. National Ankylosing Spondyloarthritis Society. November 2018.
- Ankylosing Spondylitis. MedlinePlus. March 23, 2023.
- Mauro D et al. Ankylosing Spondylitis: an Autoimmune or Autoinflammatory Disease? Nature Reviews Rheumatology. July 2021.
- Overview of Ankylosing Spondylitis. Spondylitis Association of America.
- Biologics. Arthritis Foundation. September 3, 2022.
- Medications Used to Treat Ankylosing Spondylitis and Related Diseases. Spondylitis Association of America.
- Savin E et al. Biologic Treatment Modification Efficacy in Concurrent Inflammatory Bowel Disease and Ankylosing Spondylitis: A Retrospective Cohort Study at a Single Tertiary Center. Journal of Clinical Medicine. November 17, 2023.
- Zaki A et al. Biologics in Non-Infectious Uveitis: Past, Present, and Future. Annals of Eye Science. June 15, 2021.
- Atzeni F et al. Cardiovascular Risk in Ankylosing Spondylitis and the Effect of anti-TNF Drugs: A Narrative Review. Expert Opinion on Biological Therapy. December 17, 2019.
- Ankylosing Spondylitis Medications. GoodRx.

Beth Biggee, MD
Medical Reviewer
Beth Biggee, MD, is medical director and an integrative rheumatologist at Rheumission, a virtual integrative rheumatology practice for people residing in California and Pennsylvania. This first-of-its-kind company offers whole person autoimmune care by a team of integrative rheumatologists, lifestyle medicine practitioners, autoimmune dietitians, psychologists, and care coordinators.
Dr. Biggee also works as a healthcare wellness consultant for Synergy Wellness Center in Hudson, Massachusetts. Teamed with Synergy, she provides in-person lifestyle medicine and holistic consults, and contributes to employee workplace wellness programs. She has over 20 years of experience in rheumatology and holds board certifications in rheumatology and integrative and lifestyle medicine. Dr. Biggee brings a human-centered approach to wellness rather than focusing solely on diseases.
Dr. Biggee graduated cum laude with a bachelor's degree from Canisius College, and graduated magna cum laude and as valedictorian from SUNY Health Science Center at Syracuse Medical School. She completed her internship and residency in internal medicine at Yale New Haven Hospital, completed her fellowship in rheumatology at Tufts–New England Medical Center, and completed training in integrative rheumatology at the University of Arizona Andrew Weil Center for Integrative Medicine. Following her training, she attained board certification in rheumatology and internal medicine through the American Board of Internal Medicine, attained board certification in integrative medicine through the American Board of Physician Specialties, and attained accreditation as a certified lifestyle medicine physician through the American College of Lifestyle Medicine. She is certified in Helms auricular acupuncture and is currently completing coursework for the Aloha Ayurveda integrative medicine course for physicians.
In prior roles, Dr. Biggee taught as an assistant clinical professor of medicine at Mary Imogene Bassett Hospital (an affiliate of Columbia University). She was also clinical associate of medicine at Tufts University School of Medicine and instructed "introduction to clinical medicine" for medical students at Tufts. She was preceptor for the Lawrence General Hospital Family Medicine Residency.
Dr. Biggee has published in Annals of Rheumatic Diseases, Arthritis in Rheumatism, Current Opinions in Rheumatology, Journal for Musculoskeletal Medicine, Medicine and Health Rhode Island, and Field Guide to Internal Medicine.

Ana Sandoiu
Author
Ana is a freelance medical copywriter, editor, and health journalist with a decade of experience in content creation. She loves to dive deep into the research and emerge with engaging and informative content everyone can understand. Her strength is combining scientific rigor with empathy and sensitivity, using conscious, people-first language without compromising accuracy.
Previously, she worked as a news editor for Medical News Today and Healthline Media. Her work as a health journalist has reached millions of readers, and her in-depth reporting has been cited in multiple peer-reviewed journals. As a medical copywriter, Ana has worked with award-winning digital agencies to implement marketing strategies for high-profile stakeholders. She’s passionate about health equity journalism, having conceived, written, and edited features that expose health disparities related to race, gender, and other social determinants of health.
Outside of work, she loves dancing, taking analog photos, and binge-watching all the RuPaul’s Drag Race franchises.